What Is MetaTrader 5 and How to Use It? MetaTrader 5 is one of the most widely used trading platforms in the world. It is designed to give traders access to financial markets such as forex, commodities, indices and shares through a single, powerful interface. Whether you are new to trading or already have experience, understanding how MetaTrader 5 works can help you navigate [...]
Investors Are Completely Wrong About Nvidia Stock Nvidia recently wrapped up GTC, and the math suggests the stock is still meaningfully undervalued.
A Fake headline Just Added and Erased $1.7 Trillion From the Stock Market Geopolitical headlines are whipsawing the market, and investors need to know what's real and what's noise.
Here's What Investors Need to Know About AST SpaceMobile Stock's Recent Pullback The stock has been experiencing some turbulence: Is this the right time to climb on board?
Here's ARK Innovation ETF's Vision for the Future. Do You Agree With It? Cathie Wood is very upfront about her expectations and how best to invest for them.
An Alphatec VP Sold Company Shares Worth $1.4 Million. Should Investors Avoid the Stock? This spine surgery innovator reported a notable insider sale amid a year of strong share performance.
Is LXP Industrial Trust a Buy or Sell After Pensionfund PDN Dumped Shares Worth $6.4 Million? This REIT focuses on single-tenant industrial properties nationwide, emphasizing stable cash flows and a strong dividend yield.
IREN Has a $9.7 Billion Microsoft Contract But Analysts Can't Agree on What It's Worth Wall Street can't agree on IREN, and that disconnect may be the biggest clue investors need to understand where this AI stock could go next.
1 No-Brainer Semiconductor Stock to Buy With $1,000 Right Now Taiwan Semiconductor Manufacturing is one of the best ways to invest in the chip space.
Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million This Boulder-based biotech, developing targeted cancer therapies, reported a notable insider sale as Phase 1 trials advance for key drug candidates.
RoboSense Crosses Into Profitability As Robotics Demand Powers Record Growth RoboSense Technology Co., Ltd. has reported a quarterly net profit for the first time, pointing to a turning point as its robotics-focused LiDAR shipments surged.
Progressive Had a Remarkable Run. Now Comes the Hard Part. Progressive still runs a tight underwriting ship, but the outlook for its earnings power is less certain.
Is BigBear.ai a Buy, Sell, or Hold After Its 31% Drop This Year? BigBear.ai looks broken on the surface, but this deep dive reveals why the market may still be underestimating what happens if backlog finally turns into real revenue.
Streaming Wars: 1 Netflix Rival Dominating the Industry It's time for investors to question whether Netflix is the best streaming stock out there.
Tim Draper On Bitcoin And The Future Of The Financial System: 'After The Automobile, People Still Ride Horses For A While' Venture capital legend Tim Draper has a one-line verdict on the future of banking, likening the evolution of the financial system to the historical shift from horses to automobiles.
Is State Street's SPTM a Better U.S. Market ETF Than Vanguard's VTI? Explore how sector focus and portfolio breadth set these two ultra-low-cost ETFs apart for investors seeking broad U.S. market access.
What Happens to Your 401(k) When You Die? What Heirs Need to Know in 2026. It would be tragic if you or a loved one's life savings fell into the wrong hands.
The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M Biotech innovator Liquidia, focused on therapies for rare conditions, reported a notable insider sale amid strong recent share performance.
